Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2006
03/30/2006WO2006032541A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
03/30/2006WO2006011024A3 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
03/30/2006WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
03/30/2006WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
03/30/2006WO2005047899A3 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
03/30/2006WO2005037825A3 Protein kinase inhibitors
03/30/2006US20060069256 Ophthalmic compositions for treating ocular hypertension
03/30/2006US20060069144 Chronic pain, allodynia, muscle spasticity, diarrhea, neuropathic pain; compounds have no or only minimal cardiovascular and/or sedatory activity; minimal side effects; 4-Benzo[1,2,5]thiadiazol-4-ylmethyl-1,3-dihydro-imidazole-2-thione
03/30/2006US20060069143 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
03/30/2006US20060069141 Trityl olmesartan medoxomil is reacted with an acid in a water miscible organic solvent, separating the precipitate of triphenyl carbinol from the solution of olmesartan medoxomil; solution of olmesartan medoxomil is treated with a base to obtain a precipitate of olmesartan medoxomil
03/30/2006US20060069135 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
03/30/2006US20060069126 Pharmaceutically active isoindoline derivatives
03/30/2006US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
03/30/2006US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/30/2006US20060069090 Triazine compounds
03/30/2006US20060069084 Methods of inhibiting kinases
03/30/2006US20060069077 Receptor-type kinase modulators and methods of use
03/30/2006US20060069028 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound
03/30/2006DE102004046623A1 Neue Pyrimidin-Derivate und ihre Verwendung New pyrimidine derivatives and their use
03/30/2006CA2582507A1 Compounds, compositions containing them, preparation thereof and uses thereof iii
03/30/2006CA2582492A1 Novel pyrimidine derivatives and their use
03/30/2006CA2581492A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
03/30/2006CA2581462A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
03/30/2006CA2580610A1 Diaminotriazole compounds useful as protein kinase inhibitors
03/30/2006CA2579907A1 Carbo- and hetero-cyclic antibiotics and use thereof
03/30/2006CA2578824A1 Crystalline form 2 of atrasentan hydrochloride
03/30/2006CA2577818A1 New heterocyclic amides
03/30/2006CA2543757A1 Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives
03/29/2006EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
03/29/2006EP1638961A1 Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
03/29/2006EP1638960A2 Preparation of chemical compounds
03/29/2006EP1638959A1 5ht -4 -antagonistic 4-(aminomethyl)-piperidine benzamides
03/29/2006EP1638958A1 Zwitterionic non-linear optophores and devices incorporating same
03/29/2006EP1638957A1 N-heterocyclyl phenyl-substituted cyclic ketoenols
03/29/2006EP1638955A2 Pyrimidines useful as modulators of voltage-gated ion channels
03/29/2006EP1638944A1 Tachykinin receptor antagonists
03/29/2006EP1638943A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
03/29/2006EP1638942A1 Cis-2,4,5-triaryl-imidazolines
03/29/2006EP1638934A1 3-aminopyrrolidines as inhibitors of monoamine uptake
03/29/2006EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands
03/29/2006EP1638564A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opioid receptors ligands
03/29/2006EP1638560A1 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
03/29/2006EP1539745B1 N-aryl-2-oxazolidinones and their derivatives
03/29/2006EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
03/29/2006EP0837677B1 Brominated hexahydroxybiphenyl derivatives
03/29/2006CN1753872A Process for the production of substituted nicotinic acid esters
03/29/2006CN1753793A 成像系统 Imaging Systems
03/29/2006CN1753670A Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments
03/29/2006CN1247546C Pyrazolinone derivatives
03/29/2006CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia
03/29/2006CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions
03/29/2006CN1247541C Cyclic imines as pesticides
03/28/2006US7019144 E.g. 1-(4-methanesulfonylphenyl)-5-phenyl-3-trifluoromethyl-1H-1,2,4-triazole; side effect reduction; antipyretics; analgesics; non-steroidal antiinflamatory agents; cyclooxygenase 2 inhibitors; anticarcinogenic agents; Alzheimer's disease; antiulcer agents; gastrointestinal disorders
03/28/2006US7019137 Alkylation of 2,3-dihydro-1,4-benzodioxin-5-amine in chlorobenzene using trifluoromethanesulfonic acid salts of N,N-bis(2-chloroethyl)-alanine methyl ester, to form serotonin receptor antagonists; nervous system disorders
03/28/2006US7019012 Quinazoline derivatives and pharmaceutical compositions containing them
03/28/2006US7019011 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
03/28/2006US7019006 Compounds useful as anti-inflammatory agents
03/28/2006US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor
03/28/2006US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
03/28/2006US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors
03/28/2006CA2263417C Arylalkanoylpyridazines
03/28/2006CA2244862C Substituted amide derivatives
03/28/2006CA2153805C C10 taxane derivatives and pharmaceutical compositions
03/23/2006WO2006031852A1 Vanilloid receptor ligands and their use in treatments
03/23/2006WO2006031782A2 Salvinorin derivatives as opioid receptor ligands
03/23/2006WO2006031179A1 Process for preparation of phtalimide
03/23/2006WO2006030984A1 Piperidine compound and process for preparing the same
03/23/2006WO2006030975A1 Piperidine derivatives and use thereof
03/23/2006WO2006030931A1 N-substituted n-(4-piperidinyl)amide derivative
03/23/2006WO2006030925A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
03/23/2006WO2006030807A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity
03/23/2006WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/23/2006WO2006029912A1 Indole derivatives as antiviral agents
03/23/2006WO2006029829A1 Heteroaroyl-substituted serine amides utilized as herbicides
03/23/2006WO2005120148A3 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
03/23/2006WO2005095348A3 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
03/23/2006WO2005082892A3 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
03/23/2006US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
03/23/2006US20060063932 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis
03/23/2006US20060063931 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
03/23/2006US20060063825 Crystalline form of a drug
03/23/2006US20060063809 Tri-substituted heteroaryls and methods of making and using the same
03/23/2006US20060063806 4-(4,5,6-trimethoxy-2-benzaldehyde) coumarin; fungicides, nontoxic
03/23/2006US20060063801 Anticancer therapeutics; 3-(7-Methoxy-4-oxo-4H-1-benzopyran-2-yl)-1-phenyl-1H-1,4-dihydroquinolin-4-one
03/23/2006US20060063796 Pyrazoles as inhibitors of tumor necrosis factor
03/23/2006US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
03/23/2006US20060063780 Sodium channel blockers
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity
03/23/2006CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/23/2006CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
03/23/2006CA2579143A1 Vanilloid receptor ligands and their use in treatments
03/23/2006CA2577181A1 Heteroaroyl-substituted serine amides utilized as herbicides
03/23/2006CA2568832A1 Indole derivatives as antiviral agents
03/22/2006EP1637527A1 Cannabinoid receptor modulator
03/22/2006EP1636209A1 Epoxy compound and cured epoxy resin product
03/22/2006EP1636195A1 Quinazolines and pyrido[3,4-d]pyrimidines as receptor tyrosine kinase inhibitors
03/22/2006EP1636193A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
03/22/2006EP1636189A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636160A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders